Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Growth Factors (Chur, Switzerland)
|
February 1, 2008
The antibody sc-33040-R fails to specifically recognize phosphorylation of ErbB4 on tyrosine1056
Richard M Gallo, David J Riese
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology
|
May 18, 2007
Mutational activation of ErbB family receptor tyrosine kinases: insights into mechanisms of signal transduction and tumorigenesis
David J Riese, Richard M Gallo, Jeffrey Settleman
The Biochemical Journal
|
February 1, 2006
The epidermal growth factor receptor (EGFR)-S442F mutant displays increased affinity for neuregulin-2beta and agonist-independent coupling with downstream signalling events
Jennifer L Gilmore, Richard M Gallo, David J Riese
Infection and Immunity
|
March 3, 2010
Anthrax lethal toxin impairs CD1d-mediated antigen presentation by targeting the extracellular signal-related kinase 1/2 mitogen-activated protein kinase pathway
Masood A Khan, Richard M Gallo, Randy R Brutkiewicz
Growth Factors (Chur, Switzerland)
|
December 13, 2005
Phe45 of NRG2beta is critical for the affinity of NRG2beta for ErbB4 and for potent stimulation of ErbB4 signaling by NRG2beta*
Stuart S Hobbs, Richard M Gallo, David J Riese
Viral Immunology
|
June 22, 2016
A VP22-Null HSV-1 Is Impaired in Inhibiting CD1d-Mediated Antigen Presentation
Jianyun Liu, Richard M Gallo, Carol Duffy, et al.
Biochemical and Biophysical Research Communications
|
August 29, 2006
Phosphorylation of ErbB4 on Tyr1056 is critical for inhibition of colony formation by prostate tumor cell lines
Richard M Gallo, Ianthe Bryant, Rachael Fry, et al.
Journal of Cancer Research and Therapeutic Oncology
|
May 3, 2014
Multiple Functional Motifs Are Required for the Tumor Suppressor Activity of a Constitutively-Active ErbB4 Mutant
Richard M Gallo, Ianthe N Bryant, Christopher P Mill, et al.
Immunology
|
August 12, 2015
STAT3 promotes CD1d-mediated lipid antigen presentation by regulating a critical gene in glycosphingolipid biosynthesis
Abhirami K Iyer, Jianyun Liu, Richard M Gallo, et al.
Frontiers in Immunology
|
January 23, 2018
Neurofibromin 1 Impairs Natural Killer T-Cell-Dependent Antitumor Immunity against a T-Cell Lymphoma
Jianyun Liu, Richard M Gallo, Masood A Khan, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Growth Factors (Chur, Switzerland)
|
February 1, 2008
The antibody sc-33040-R fails to specifically recognize phosphorylation of ErbB4 on tyrosine1056
Richard M Gallo, David J Riese
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology
|
May 18, 2007
Mutational activation of ErbB family receptor tyrosine kinases: insights into mechanisms of signal transduction and tumorigenesis
David J Riese, Richard M Gallo, Jeffrey Settleman
The Biochemical Journal
|
February 1, 2006
The epidermal growth factor receptor (EGFR)-S442F mutant displays increased affinity for neuregulin-2beta and agonist-independent coupling with downstream signalling events
Jennifer L Gilmore, Richard M Gallo, David J Riese
Infection and Immunity
|
March 3, 2010
Anthrax lethal toxin impairs CD1d-mediated antigen presentation by targeting the extracellular signal-related kinase 1/2 mitogen-activated protein kinase pathway
Masood A Khan, Richard M Gallo, Randy R Brutkiewicz
Growth Factors (Chur, Switzerland)
|
December 13, 2005
Phe45 of NRG2beta is critical for the affinity of NRG2beta for ErbB4 and for potent stimulation of ErbB4 signaling by NRG2beta*
Stuart S Hobbs, Richard M Gallo, David J Riese
Viral Immunology
|
June 22, 2016
A VP22-Null HSV-1 Is Impaired in Inhibiting CD1d-Mediated Antigen Presentation
Jianyun Liu, Richard M Gallo, Carol Duffy, et al.
Biochemical and Biophysical Research Communications
|
August 29, 2006
Phosphorylation of ErbB4 on Tyr1056 is critical for inhibition of colony formation by prostate tumor cell lines
Richard M Gallo, Ianthe Bryant, Rachael Fry, et al.
Journal of Cancer Research and Therapeutic Oncology
|
May 3, 2014
Multiple Functional Motifs Are Required for the Tumor Suppressor Activity of a Constitutively-Active ErbB4 Mutant
Richard M Gallo, Ianthe N Bryant, Christopher P Mill, et al.
Immunology
|
August 12, 2015
STAT3 promotes CD1d-mediated lipid antigen presentation by regulating a critical gene in glycosphingolipid biosynthesis
Abhirami K Iyer, Jianyun Liu, Richard M Gallo, et al.
Frontiers in Immunology
|
January 23, 2018
Neurofibromin 1 Impairs Natural Killer T-Cell-Dependent Antitumor Immunity against a T-Cell Lymphoma
Jianyun Liu, Richard M Gallo, Masood A Khan, et al.
Page
of 2